LINC01559

Across TCGA pan-cancer cohorts, LINC01559 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated LINC01559 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01559 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01559 expression acts as an unfavorable survival marker.

HNSC, BRCA, and LUAD are the cancer types where LINC01559 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.198	0.661	.011	27	view →
BRCA	OS	Median	II,III,IV	0.667	0.958	<.001	22	view →
LUAD	DFS	Median	All	0.036	0.791	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

LINC01559–HNSC (OS)

Open the HNSC breakdown →